Research programme: RSV-influenza combination vaccine - NovavaxAlternative Names: Combination seasonal influenza-RSV nanoparticle vaccine - Novavax; Combination seasonal influenza-RSV vaccine - Novavax; Combo RSV/Flu vaccine - Novavax; RSV-influenza nanoparticle vaccine - Novavax; RSV-influenza vaccine - Novavax; RSV/Flu vaccine - Novavax
Latest Information Update: 08 Jun 2016
At a glance
- Originator Novavax
- Class Influenza virus vaccines; Protein-vaccines; Recombinant fusion proteins; Respiratory syncytial virus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza virus infections; Respiratory syncytial virus infections